Poly(vinylphosphonic acid-co-acrylic acid) (PVPA-co-AA) has recently
been identified as a possible candidate
for use in bone tissue engineering. It is hypothesized that the strong
binding of PVPA-co-AA to calcium in natural bone
inhibits osteoclast activity. The free radical polymerization of acrylic
acid (AA) with vinylphosphonic acid (VPA) has been investigated with
varying experimental conditions. A range of copolymers were successfully
produced and their compositions were determined quantitatively using 31P NMR spectroscopy. Monomer conversions were calculated using 1H NMR spectroscopy and a general decrease was found with increasing
VPA content. Titration studies demonstrated an increase in the degree
of dissociation as a function of VPA in the copolymer. However, a
VPA content ca. 30 mol % was found to be the optimum
for calcium chelation, suggesting that this composition is the most
promising for biomaterials applications. Assessment of cell metabolic
activity showed that PVPA-co-AA has no detrimental
effect on cells, regardless of copolymer composition.